Link between type 2 diabetes mellitus and hepatocellular carcinoma

doi:10.4254/wjh.v17.i7.107675

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (136)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

HTML

Figures (1-2)

Sum=114

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=17

Jul 27, 2025 (publication date) through Jul 28, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Jul 27, 2025; 17(7): 107675
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.107675

Full Size Figure Download Figure

Figure 1 Metabolic alteration that leads to hepatocellular carcinoma. PI3K: Phosphoinositide 3-kinase; AKT: Protein kinase B; mTOR: Mammalian target of rapamycin; ER: Endoplasmic reticulum; MAPK: Mitogen-activated protein kinase.

Citation: Giri S, Mukhuty A, Mondal SA, Sahoo J, Roy A, Kamalanathan S, Naik D. Link between type 2 diabetes mellitus and hepatocellular carcinoma. World J Hepatol 2025; 17(7): 107675
URL: https://www.wjgnet.com/1948-5182/full/v17/i7/107675.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i7.107675